{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T19:27:22Z","timestamp":1794425242155,"version":"4.9.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","award":["JPMJCR18H1"],"award-info":[{"award-number":["JPMJCR18H1"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"JST","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018984","name":"Institute of Medical Science, University of Tokyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004721","name":"University of Tokyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20nk0101625h0201"],"award-info":[{"award-number":["JP20nk0101625h0201"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0108113h0001"],"award-info":[{"award-number":["JP20fk0108113h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP223fa627001"],"award-info":[{"award-number":["JP223fa627001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.coviro.2026.101543","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:23:22Z","timestamp":1777595002000},"page":"101543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["STING agonists as next-generation vaccine adjuvants: mechanisms, opportunities, and challenges"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5189-3529","authenticated-orcid":false,"given":"Burcu","family":"Temizoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken J","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2026.101543_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib2","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.coviro.2026.101543_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/317537","article-title":"Type 1\/Type 2 immunity in infectious diseases","volume":"32","author":"Spellberg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2026.101543_bib4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.immuni.2011.10.018","article-title":"Th17 cells mediate clade-specific, serotype-independent mucosal immunity","volume":"35","author":"Chen","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2026.101543_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2011.01051.x","article-title":"Cytoplasmic DNA innate immune pathways","volume":"243","author":"Barber","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coviro.2026.101543_bib6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","article-title":"Cyclic GMP-AMP containing mixed Phosphodiester linkages is an endogenous high-affinity ligand for STING","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.coviro.2026.101543_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri3247","article-title":"Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination","volume":"12","author":"Desmet","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib8","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coviro.2026.101543_bib9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I IFN pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coviro.2026.101543_bib10","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/j.vaccine.2011.05.026","article-title":"Bis-(3\u2019,5\u2019)-cyclic dimeric adenosine monophosphate: strong Th1\/Th2\/Th17 promoting mucosal adjuvant","volume":"29","author":"Ebensen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2026.101543_sbref11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41586-025-08758-w","article-title":"STING agonist-based ER-targeting molecules boost antigen cross-presentation","volume":"641","author":"Wang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2026.101543_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2026.101543_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0077846","article-title":"Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides","volume":"8","author":"Yi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2026.101543_bib14","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.4049\/jimmunol.1300097","article-title":"Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid","volume":"190","author":"Conlon","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2026.101543_bib16","first-page":"6","article-title":"The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant","volume":"8","author":"Tang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2026.101543_bib17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/eji.201445132","article-title":"TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN","volume":"45","author":"Temizoz","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib18","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.immuni.2022.08.006","article-title":"ABCC1 transporter exports the immunostimulatory cyclic dinucleotide cGAMP","volume":"55","author":"Maltbaek","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2026.101543_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.molcel.2019.05.006","article-title":"SLC19A1 Is an Importer of the Immunotransmitter cGAMP","volume":"75","author":"Ritchie","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.coviro.2026.101543_bib20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/acscentsci.1c00440","article-title":"Human SLC46A2 is the dominant cGAMP importer in extracellular cGAMP-sensing macrophages and monocytes","volume":"7","author":"Cordova","year":"2021","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.coviro.2026.101543_bib21","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1021\/acs.molpharmaceut.5c01263","article-title":"Targeting the cGAS-STING pathway for cancer immunotherapy: from small-molecule agonists to advanced nanomaterials","volume":"22","author":"Guo","year":"2025","journal-title":"Mol Pharm"},{"key":"10.1016\/j.coviro.2026.101543_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2023.03.036","article-title":"STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applications","volume":"357","author":"Xu","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.coviro.2026.101543_bib23","first-page":"1","article-title":"Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.coviro.2026.101543_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ebiom.2016.05.039","article-title":"Ligand-induced Ordering of the C-terminal tail primes STING for phosphorylation by TBK1","volume":"9","author":"Tsuchiya","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2026.101543_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41586-019-1006-9","article-title":"Autophagy induction via STING trafficking is a primordial function of the cGAS pathway","volume":"567","author":"Gui","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2026.101543_bib26","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s44319-023-00045-x","article-title":"A conserved ion channel function of STING mediates noncanonical autophagy and cell death","volume":"25","author":"Xun","year":"2024","journal-title":"EMBO Rep"},{"key":"10.1016\/j.coviro.2026.101543_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms11932","article-title":"Activation of STING requires palmitoylation at the Golgi","volume":"7","author":"Mukai","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2026.101543_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2024.11.017","article-title":"The cGAS-STING pathway activates transcription factor TFEB to stimulate lysosome biogenesis and pathogen clearance","volume":"58","author":"Xu","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2026.101543_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1008335","article-title":"STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection","volume":"16","author":"Wang","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2026.101543_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2024.1353336","article-title":"5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation","volume":"15","author":"Temizoz","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib31","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.celrep.2014.08.010","article-title":"Binding-pocket and lid-region substitutions render human STING sensitive to the species-specific drug DMXAA","volume":"8","author":"Gao","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2026.101543_bib32","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1158\/0008-5472.CAN-15-1456","article-title":"STING promotes the growth of tumors characterized by low antigenicity via IDO activation","volume":"76","author":"Lemos","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.coviro.2026.101543_bib33","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.celrep.2018.04.003","article-title":"STING-activating adjuvants elicit a Th17 immune response and protect against Mycobacterium tuberculosis infection","volume":"23","author":"Van Dis","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2026.101543_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02212","article-title":"Cyclic GMP-AMP triggers asthma in an IL-33-dependent manner that is blocked by amlexanox, a TBK1 inhibitor","volume":"10","author":"Ozasa","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib35","first-page":"1","article-title":"STING is required for host defense against neuropathological West Nile virus infection","volume":"15","author":"Wuertz","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2026.101543_sbref36","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2022.04.006","article-title":"The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis","volume":"55","author":"Erttmann","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2026.101543_sbref37","article-title":"Herpes simplex virus 1 encodes a STING antagonist that can be therapeutically targeted","volume":"6","author":"Wang","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.coviro.2026.101543_sbref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-43635-y","article-title":"The poxvirus F17 protein counteracts mitochondrially orchestrated antiviral responses","volume":"14","author":"Meade","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2026.101543_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.02145-17","article-title":"Virulent poxviruses inhibit DNA sensing by preventing STING activation","volume":"92","author":"Georgana","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2026.101543_bib40","first-page":"1","article-title":"Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity","volume":"6","author":"Tursi","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.coviro.2026.101543_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-024-00914-z","article-title":"A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity","volume":"9","author":"Zhao","year":"2024","journal-title":"Npj Vaccin"},{"key":"10.1016\/j.coviro.2026.101543_bib42","doi-asserted-by":"crossref","unstructured":"W. Hong, P. Cheng, J. Yang, H. Shi, Z. Wang, J. Li, H. Lei, D. Peng, C. He, W. Ren, X. Pan, Y. Huang, A. Alu, F. Qin, B. Wang, Y. Zhou, Y. Yang, W. Yu, C. Tang, Q. Huang, M. Yang, B. Li, J. Li, J. Wang, J. Ai, L. Chen, H. Que, Z. Zeng, J. Liu, Y. Hao, D. Ao, Y. Zhang, X. Huang, C. Ye, M.Y. Fu, X. He, Z. Bi, X. Han, M. Luo, H. Hu, W. Cheng, H. Dong, J. Lei, L. Chen, X. Zhou, W. Wang, G. Shen, J. Yang, X. Song, Y. Wei, S. Lu, Q. Sun, G. Lu, Y. Wang, L. Yang, W. Li, X. Wei, Intranasal Vaccine Combining Adenovirus and Trimeric Subunit Protein Provides Superior Immunity Against SARS-CoV-2 Omicron Variant; 2025. doi: \u300810.1038\/s41551-025-01517-2\u3009.","DOI":"10.1038\/s41551-025-01517-2"},{"key":"10.1016\/j.coviro.2026.101543_bib43","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.aau0810","article-title":"Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity","volume":"367","author":"Wang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2026.101543_bib44","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jconrel.2022.05.017","article-title":"STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant","volume":"347","author":"Gallovic","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.coviro.2026.101543_bib45","first-page":"1","article-title":"Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.coviro.2026.101543_bib46","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.ymthe.2021.03.002","article-title":"mRNA-encoded, constitutively active STINGV155M is a potent genetic adjuvant of antigen-specific CD8+ T cell response","volume":"29","author":"Tse","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.coviro.2026.101543_bib47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-022-00612-2","article-title":"A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs","volume":"32","author":"Liu","year":"2022","journal-title":"Cell Res"},{"key":"10.1016\/j.coviro.2026.101543_bib48","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1021\/acs.nanolett.2c04883","article-title":"STING agonist-derived LNP-mRNA vaccine enhances protective immunity against SARS-CoV-2","volume":"23","author":"Zhang","year":"2023","journal-title":"Nano Lett"},{"key":"10.1016\/j.coviro.2026.101543_bib49","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1016\/j.vaccine.2015.07.103","article-title":"Management and outcome of Bacille Calmette-Gu\u00e9rin vaccine adverse reactions","volume":"33","author":"Venkataraman","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2026.101543_bib50","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/infdis\/jiz116","article-title":"Bacillus calmette-guerin overexpressing an endogenous stimulator of interferon genes agonist provides enhanced protection against pulmonary tuberculosis","volume":"221","author":"Dey","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2026.101543_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.943667","article-title":"Cyclic di-AMP as endogenous adjuvant enhanced BCG- induced trained immunity and protection against Mycobacterium tuberculosis in mice","volume":"13","author":"Ning","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib52","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2026.101543_bib53","first-page":"1","article-title":"The chitosan nanoparticle-based adjuvant CH-100 orchestrates multifaceted innate immune activation via STING-dependent and -independent pathways","volume":"00","author":"Nagai","year":"2025","journal-title":"Int Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib54","doi-asserted-by":"crossref","first-page":"10439","DOI":"10.1021\/acsnano.3c11374","article-title":"Self-assembled STING-activating coordination nanoparticles for cancer immunotherapy and vaccine applications","volume":"18","author":"Sun","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.coviro.2026.101543_bib55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4049\/jimmunol.2300038","article-title":"TLR9 plus STING agonist adjuvant combination induces potent neopeptide T cell immunity and improves immune checkpoint blockade efficacy in a tumor model","volume":"212","author":"Castro Eiro","year":"2024","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib56","first-page":"85","article-title":"Vaccine adjuvants as stand-alone immunoprophylaxis in strategies for 100-day rapid responses to future pandemics","author":"Kavian","year":"2025","journal-title":"Int Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib57","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2026.101543_bib58","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.abb4255","article-title":"Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic","volume":"369","author":"Chin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2026.101543_bib59","doi-asserted-by":"crossref","first-page":"dxac012","DOI":"10.1093\/intimm\/dxac012","article-title":"Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation","volume":"34","author":"Temizoz","year":"2022","journal-title":"Int Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.coph.2018.05.003","article-title":"Combination and inducible adjuvants targeting nucleic acid sensors","volume":"41","author":"Temizoz","year":"2018","journal-title":"Curr Opin Pharm"},{"key":"10.1016\/j.coviro.2026.101543_bib61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11912-023-01361-0","article-title":"The development of STING agonists and emerging results as a cancer immunotherapy","volume":"25","author":"Hines","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.coviro.2026.101543_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms6166","article-title":"Inflammation-driven carcinogenesis is mediated through STING","volume":"5","author":"Ahn","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2026.101543_bib63","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.celrep.2013.05.009","article-title":"The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING","volume":"3","author":"Diner","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2026.101543_bib64","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4049\/jimmunol.1601585","article-title":"The common R71H-G230A-R293Q (HAQ) human TMEM173 is a null allele","volume":"198","author":"Patel","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib65","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1172\/JCI79100","article-title":"Inherited STING-activating mutation underlies a familial inflammatory","volume":"124","author":"Jeremiah","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2026.101543_sbref65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103434","article-title":"Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides","volume":"154","author":"Shibahara","year":"2025","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coviro.2026.101543_sbref66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.adm6843","article-title":"OTUD3 prevents ulcerative colitis by inhibiting microbiota-mediated STING activation","volume":"10","author":"Li","year":"2025","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","article-title":"The cGAS\u2013STING pathway drives type I IFN immunopathology in COVID-19","volume":"603","author":"Domizio","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2026.101543_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/acel.13594","article-title":"Dysfunctional telomeres through mitostress-induced cGAS\/STING activation to aggravate immune senescence and viral pneumonia","volume":"21","author":"Lv","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.coviro.2026.101543_bib70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4049\/jimmunol.1601999","article-title":"Activation of STING in T cells induces type I IFN responses and cell death","volume":"199","author":"Larkin","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embr.202255536","article-title":"STING agonism turns human T cells into interferon-producing cells but impedes their functionality","volume":"24","author":"Kuhl","year":"2023","journal-title":"EMBO Rep"},{"key":"10.1016\/j.coviro.2026.101543_bib72","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/s41423-020-00552-0","article-title":"STING regulates BCR signaling in normal and malignant B cells","volume":"18","author":"Tang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.coviro.2026.101543_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.abi9002","article-title":"A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection","volume":"6","author":"Humphries","year":"2021","journal-title":"Sci Immunol"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625726000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625726000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T19:19:47Z","timestamp":1794424787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625726000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":73,"alternative-id":["S1879625726000350"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2026.101543","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STING agonists as next-generation vaccine adjuvants: mechanisms, opportunities, and challenges","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2026.101543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101543"}}